Efficacy and Safety Study in Subjects With Asthma

NCT00980200 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Dose 4 QD
DRUG: Dose 3 QD
DRUG: placebo
DRUG: Dose 2 QD
DRUG: Dose 1 BD

Sponsor

GlaxoSmithKline